Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LIMAPROST vs LINAGLIPTIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LIMAPROST vs LINAGLIPTIN: Safety Overview

Metric LIMAPROST LINAGLIPTIN
Total FAERS Reports 136 7,762
Deaths Reported 25 726
Death Rate 18.4% 9.4%
Hospitalizations 79 2,794
Average Patient Age 76.3 yrs 70.2 yrs
% Female Patients 50.4% 51.8%
FDA Approval Date N/A Aug 31, 2021
Manufacturer N/A Novadoz Pharmaceuticals LLC
Route N/A ORAL
Marketing Status N/A Prescription